59 related articles for article (PubMed ID: 21607858)
1. Machine learning approaches in predicting allosteric sites.
Nerín-Fonz F; Cournia Z
Curr Opin Struct Biol; 2024 Apr; 85():102774. PubMed ID: 38354652
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of allosteric modulators: A case for chemokine receptors.
den Hollander LS; IJzerman AP; Heitman LH
Med Res Rev; 2024 Apr; ():. PubMed ID: 38634664
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel positive allosteric modulator of the α
Papay RS; Macdonald JD; Stauffer SR; Perez DM
Curr Res Pharmacol Drug Discov; 2023; 4():100142. PubMed ID: 36544813
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of β
Liu X; Masoudi A; Kahsai AW; Huang LY; Pani B; Staus DP; Shim PJ; Hirata K; Simhal RK; Schwalb AM; Rambarat PK; Ahn S; Lefkowitz RJ; Kobilka B
Science; 2019 Jun; 364(6447):1283-1287. PubMed ID: 31249059
[TBL] [Abstract][Full Text] [Related]
5. Small-Molecule Positive Allosteric Modulators of the
Ahn S; Pani B; Kahsai AW; Olsen EK; Husemoen G; Vestergaard M; Jin L; Zhao S; Wingler LM; Rambarat PK; Simhal RK; Xu TT; Sun LD; Shim PJ; Staus DP; Huang LY; Franch T; Chen X; Lefkowitz RJ
Mol Pharmacol; 2018 Aug; 94(2):850-861. PubMed ID: 29769246
[TBL] [Abstract][Full Text] [Related]
6. Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.
Ahn S; Kahsai AW; Pani B; Wang QT; Zhao S; Wall AL; Strachan RT; Staus DP; Wingler LM; Sun LD; Sinnaeve J; Choi M; Cho T; Xu TT; Hansen GM; Burnett MB; Lamerdin JE; Bassoni DL; Gavino BJ; Husemoen G; Olsen EK; Franch T; Costanzi S; Chen X; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1708-1713. PubMed ID: 28130548
[TBL] [Abstract][Full Text] [Related]
7. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
8. A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias.
Bolognini D; Moss CE; Nilsson K; Petersson AU; Donnelly I; Sergeev E; König GM; Kostenis E; Kurowska-Stolarska M; Miller A; Dekker N; Tobin AB; Milligan G
J Biol Chem; 2016 Sep; 291(36):18915-31. PubMed ID: 27385588
[TBL] [Abstract][Full Text] [Related]
9. Drug Design Strategies for GPCR Allosteric Modulators.
Conn PJ; Kuduk SD; Doller D
Annu Rep Med Chem; 2012; 47():441-457. PubMed ID: 26962268
[No Abstract] [Full Text] [Related]
10. Co-operative binding assay for the characterization of mGlu4 allosteric modulators.
Poutiainen P; Kil KE; Zhang Z; Kuruppu D; Tannous B; Brownell AL
Neuropharmacology; 2015 Oct; 97():142-8. PubMed ID: 26025660
[TBL] [Abstract][Full Text] [Related]
11. International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands.
Christopoulos A; Changeux JP; Catterall WA; Fabbro D; Burris TP; Cidlowski JA; Olsen RW; Peters JA; Neubig RR; Pin JP; Sexton PM; Kenakin TP; Ehlert FJ; Spedding M; Langmead CJ
Pharmacol Rev; 2014 Oct; 66(4):918-47. PubMed ID: 25026896
[TBL] [Abstract][Full Text] [Related]
12. Approaches for probing allosteric interactions at 7 transmembrane spanning receptors.
Klein MT; Vinson PN; Niswender CM
Prog Mol Biol Transl Sci; 2013; 115():1-59. PubMed ID: 23415091
[TBL] [Abstract][Full Text] [Related]
13. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
14. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions.
Avlani VA; McLoughlin DJ; Sexton PM; Christopoulos A
J Pharmacol Exp Ther; 2008 Jun; 325(3):927-34. PubMed ID: 18322151
[TBL] [Abstract][Full Text] [Related]
15. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
[TBL] [Abstract][Full Text] [Related]
16. Allosteric properties of G protein-coupled receptor oligomers.
Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
Urwyler S
Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
[TBL] [Abstract][Full Text] [Related]
18. Determining allosteric modulator mechanism of action: integration of radioligand binding and functional assay data.
Langmead CJ
Methods Mol Biol; 2011; 746():195-209. PubMed ID: 21607858
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
